glp-1 receptor agonist use and risk of suicide death Postmarket safety profile suicide/self-injury for agonist: a real-world pharmacovigilance analysis | European Psychiatry GLP-1 Agonists in Cardiovascular Diseases:
Description
Safety Considerations : Common side effects include nausea and gastrointestinal issues, but these often improve with gradual dosage adjustments
Front Psychol
Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1c targets
Rare Risks: Though uncommon, serious complications such as gallbladder issues or pancreatitis can occur
The mechanism of action involves multiple pathways
[DOI] [PubMed] [Google Scholar] 131.Florez J.C., Pearson E.R
